Guiling Li Yao Jiang
10.3389/fonc.2022.916790
Front Oncol
2022 Jul 12;12:916790.
smarca4 mutation anti-pd-1 antibody antiangiogenic drug next-generation sequencing small cell carcinoma of the ovary hypercalcemic type
CC BY
https://pubmed.ncbi.nlm.nih.gov/35903699/
Case Reports
PMC9315103
35903699
Case Report: A Durable Response to Camrelizumab and Apatinib Combination Therapy in a Heavily Treated Small Cell Carcinoma of the Ovary, Hypercalcemic Type
2022